AR120095A1 - ANTIGEN-BINDING PROTEINS - Google Patents

ANTIGEN-BINDING PROTEINS

Info

Publication number
AR120095A1
AR120095A1 ARP200102674A ARP200102674A AR120095A1 AR 120095 A1 AR120095 A1 AR 120095A1 AR P200102674 A ARP200102674 A AR P200102674A AR P200102674 A ARP200102674 A AR P200102674A AR 120095 A1 AR120095 A1 AR 120095A1
Authority
AR
Argentina
Prior art keywords
antigen
binding proteins
compositions
treatment
present disclosure
Prior art date
Application number
ARP200102674A
Other languages
Spanish (es)
Inventor
Yan Y Degenhardt
Jun Guan
Kenneth William Hance
Peter Joseph Morley
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of AR120095A1 publication Critical patent/AR120095A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente divulgación se refiere a composiciones para el tratamiento de las enfermedades mediadas por CD96 y los procedimientos conexos.The present disclosure relates to compositions for the treatment of CD96-mediated diseases and related methods.

ARP200102674A 2019-09-27 2020-09-25 ANTIGEN-BINDING PROTEINS AR120095A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962906876P 2019-09-27 2019-09-27

Publications (1)

Publication Number Publication Date
AR120095A1 true AR120095A1 (en) 2022-02-02

Family

ID=80633301

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200102674A AR120095A1 (en) 2019-09-27 2020-09-25 ANTIGEN-BINDING PROTEINS

Country Status (1)

Country Link
AR (1) AR120095A1 (en)

Similar Documents

Publication Publication Date Title
CO2021005987A2 (en) Fused ring compounds
CO2017011484A2 (en) Bromodomain inhibitors
CL2020003105A1 (en) Bispecific antibodies against dll3-cd3
CL2017001204A1 (en) 6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
CO2019007863A2 (en) Benzooxazole derivatives as immunomodulators
ECSP19021312A (en) HIGHLY CONCENTRATED, LOW VISCOSITY, MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS, AND METHODS
CL2018001685A1 (en) Heterocyclic compounds as immuno modulators.
CO2017000399A2 (en) Mitogen Activated Protein Kinase (MNK) Interaction Kinase Inhibitors and Related Methods
ECSP17083788A (en) ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF LIGHT CHAIN AMYLOIDOSIS AND OTHER CD38-POSITIVE HEMATOLOGIC MALIGNANT DISEASES
ECSP19043710A (en) AMINO ACID COMPOSITIONS AND METHODS OF TREATMENT OF LIVER DISEASES
BR112021024236A2 (en) multispecific proteins
CO2019014286A2 (en) Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
CR20160496A (en) SUBSTITUTED SIPROCYCLIC INHIBITORS OF AUTOTAXINE
CL2018001569A1 (en) Heteroaromatic compounds as btk inhibitors
CL2021001395A1 (en) Compounds derived from cyclic pantheines; pharmaceutical composition comprising them; and its use to increase the concentrations of acetyl-coa, for the treatment of cancer, inflammatory disease, neurodegenerative disease, multiple sclerosis, among other diseases.
CO2019009423A2 (en) Piperidine Substituted MNK Inhibitors and Related Methods
EA201890572A1 (en) BIOPHARMACEUTICAL COMPOSITIONS
CL2019001749A1 (en) Use of anti-sclerostin antibodies in the treatment of imperfect osteogenesis.
CL2022000967A1 (en) Compositions and methods for the treatment of liver diseases
CL2021001198A1 (en) Heteroaromatic compounds as vanine inhibitors
CL2018003377A1 (en) Novel compounds to treat parasitic diseases. (divisional application 201803187)
EA201791807A1 (en) NEW TRITERPENON WITH C-3 WITH REVERSE AMIDIC DERIVATIVES WITH C-17 AS HIV INHIBITORS
CL2020003348A1 (en) Anti-cd40 antibodies for use in the treatment of autoimmune diseases
CL2021002182A1 (en) Formulation of therapeutic antibodies
EA201792610A1 (en) METHOD OF TREATMENT OF NEUROLOGICAL DISEASE